Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579939 · ClinicalTrials.gov registry record · NA
Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04579939: Completed NA study, sponsored by Mayo Clinic.
NCT04579939 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04579939, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study aims to determine if a popular dextrose candy alternative yields a similar glycemic curve compared to the standard oral Dextrose solution used in the Oral Glucose Tolerance Test.
Primary Outcome
The investigators will obtain glucose values at standard clinical times for oral glucose tolerance testing
Interventions
- DIAGNOSTIC_TEST Candy Glucose Tolerance Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2021-12-30 |
| Phase | NA |
What the finished NCT04579939 record still lists
NCT04579939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Candy Glucose Tolerance Test is the first listed.
NCT04579939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04579939 about?
NCT04579939 is a clinical study titled "Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis". The study aims to determine if a popular dextrose candy alternative yields a similar glycemic curve compared to the standard oral Dextrose solution used in the Oral Glucose Tolerance Test.
What is the current status of trial NCT04579939?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-02-25. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT04579939?
The interventions under investigation include: Candy Glucose Tolerance Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04579939?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04579939's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI